Computationally drived peptide based binder
PepDRED transforms peptide design by integrating advanced computational tools into an intuitive platform for non-computational biologists. It enables precise control of peptide modifications, fostering innovation in peptide development
Our technology is amenable and can be modulated according to the goal. It’s simple to use and is reproducible.
- Microbial diagnostics
- Infection prevention
- Antimicrobial stewardship
- Antimicrobial compound/strategy
- Removal antibiotics/bacteria
Microorganisms:
- Bacteria
- Viruses
- Fungi
- Yeasts
- Parasites
Application:
- Human
- Veterinary
- AgriFood
- Environmental
- Other
Development stage:
- Research
- Development
- Validation
- Market entry
- Marketed product
- Academia
- Company
- Institute
- NGO
- Government
Partnering:
- Co-develop
- Outsource
- Joint Venture
- License
- Sell
Funding organisation:
- OTHER / NA
- CARB-X
- FIND
- GARDP
- REPAIR
Infectious disease area:
- UTI
- STI
- BSI
- RTI
- GII
- SSTI
- CNSI
- IAI
- SSI
Geographic origin:
- North America
- South America
- Eurasia
- Africa
- Oceania
N.A.
Our group is interested in developing enabling technologies to facilitate disease diagnostics and control with trace amount of clinical samples. The major technologies developed in our lab include single-cell Mass Cytometry (CyTOF), tissue in situ single cell high-throughput target analysis (mass spectrum imaging), single-cell Western Blot, Feedback System Control (FSC) for rapid combinatorial drug development, Artificial Intelligence guided large-scale drug-drug integration analysis (AI-Medicine), microfluidic devices for rare patient sample handling, BioMEMS and Biosensors for disease early diagnostics.
Our lab also work on lab on chip and microfluidics based chip design for drug formulations and cell separation.
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!